These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 30184431)

  • 1. Curcumin-Loaded Liquid Crystalline Systems for Controlled Drug Release and Improved Treatment of Vulvovaginal Candidiasis.
    Rodero CF; Fioramonti Calixto GM; Cristina Dos Santos K; Sato MR; Aparecido Dos Santos Ramos M; Miró MS; Rodríguez E; Vigezzi C; Bauab TM; Sotomayor CE; Chorilli M
    Mol Pharm; 2018 Oct; 15(10):4491-4504. PubMed ID: 30184431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p-Coumaric acid loaded into liquid crystalline systems as a novel strategy to the treatment of vulvovaginal candidiasis.
    Ferreira PS; Victorelli FD; Rodero CF; Fortunato GC; Araújo VHS; Fonseca-Santos B; Bauab TM; Van Dijck P; Chorilli M
    Int J Pharm; 2021 Jun; 603():120658. PubMed ID: 33964336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A curcumin-loaded liquid crystal precursor mucoadhesive system for the treatment of vaginal candidiasis.
    Salmazi R; Calixto G; Bernegossi J; Ramos MA; Bauab TM; Chorilli M
    Int J Nanomedicine; 2015; 10():4815-24. PubMed ID: 26257519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo study of hypericin-loaded poloxamer-based mucoadhesive in situ gelling liquid crystalline precursor system in a mice model of vulvovaginal candidiasis.
    de Araújo PR; Calixto GMF; Araújo VHS; Sato MR; Rodero CF; Oshiro-Junior JA; Bauab TM; Chorilli M
    Med Mycol; 2021 Jul; 59(8):821-827. PubMed ID: 33626136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid crystal precursor mucoadhesive system as a strategy to improve the prophylactic action of Syngonanthus nitens (Bong.) Ruhland against infection by Candida krusei.
    dos Santos Ramos MA; Calixto G; de Toledo LG; Bonifácio BV; dos Santos LC; de Almeida MT; Chorilli M; Bauab TM
    Int J Nanomedicine; 2015; 10():7455-66. PubMed ID: 26719688
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Fonseca-Santos B; Bonifácio BV; Baub TM; Gremião MPD; Chorilli M
    J Biomed Nanotechnol; 2019 Jun; 15(6):1334-1344. PubMed ID: 31072440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface-modified mucoadhesive microgels as a controlled release system for miconazole nitrate to improve localized treatment of vulvovaginal candidiasis.
    Kenechukwu FC; Attama AA; Ibezim EC; Nnamani PO; Umeyor CE; Uronnachi EM; Gugu TH; Momoh MA; Ofokansi KC; Akpa PA
    Eur J Pharm Sci; 2018 Jan; 111():358-375. PubMed ID: 28986195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pulsatilla decoction inhibits vulvovaginal Candida albicans proliferation and reduces inflammatory cytokine levels in vulvovaginal candidiasis mice].
    Xia D; Zhang M; Shi G; Xu Z; Wu D; Shao J; Wang T; Wang C
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):153-7. PubMed ID: 26927371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of curcumin in the treatment of experimental vulvovaginal candidiasis.
    Andrade JT; Fantini de Figueiredo G; Cruz LF; Eliza de Morais S; Souza CDF; Pinto FCH; Ferreira JMS; Araújo MGF
    Rev Iberoam Micol; 2019; 36(4):192-199. PubMed ID: 31757595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of mucoadhesive thermoresponsive systems containing propolis for the treatment of vulvovaginal candidiasis.
    Pereira RR; Ribeiro Godoy JS; Stivalet Svidzinski TI; Bruschi ML
    J Pharm Sci; 2013 Apr; 102(4):1222-34. PubMed ID: 23334938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma-based strategy for inhibiting Candida albicans growth and CaMCA1 gene expression in vitro and reducing fungal pathogenicity in a murine model of vulvovaginal candidiasis.
    Ebrahimi-Shaghaghi F; Atyabi SM; Razzaghi-Abyaneh M
    Med Mycol; 2021 Dec; 60(1):. PubMed ID: 34694384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis.
    Gao M; Wang H; Zhu L
    Cell Physiol Biochem; 2016; 40(3-4):727-742. PubMed ID: 27915337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nystatin enhances the immune response against Candida albicans and protects the ultrastructure of the vaginal epithelium in a rat model of vulvovaginal candidiasis.
    Zhang X; Li T; Chen X; Wang S; Liu Z
    BMC Microbiol; 2018 Oct; 18(1):166. PubMed ID: 30359236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and in vivo evaluation of chitosan-gel containing Mitracarpus frigidus methanolic extract for vulvovaginal candidiasis treatment.
    Campos LM; de Oliveira Lemos AS; da Cruz LF; de Freitas Araújo MG; de Mello Botti GCR; Júnior JLR; Rocha VN; Denadai ÂML; da Silva TP; Tavares GD; Scio E; Fabri RL; Pinto PF
    Biomed Pharmacother; 2020 Oct; 130():110609. PubMed ID: 34321177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan and liposomal delivery systems for epicatechin or propyl gallate targeting localized treatment of vulvovaginal candidiasis.
    Mork S; Johannessen M; Škalko-Basnet N; Jøraholmen MW
    Int J Pharm; 2024 Sep; 662():124489. PubMed ID: 39032871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of the clinical agent VT-1161 against fluconazole-sensitive and -resistant Candida albicans in a murine model of vaginal candidiasis.
    Garvey EP; Hoekstra WJ; Schotzinger RJ; Sobel JD; Lilly EA; Fidel PL
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5567-73. PubMed ID: 26124165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syngonanthus nitens Bong. (Rhul.)-Loaded Nanostructured System for Vulvovaginal Candidiasis Treatment.
    Dos Santos Ramos MA; de Toledo LG; Calixto GM; Bonifácio BV; de Freitas Araújo MG; Dos Santos LC; de Almeida MT; Chorilli M; Bauab TM
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27556451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved in vitro and in vivo Anti-
    Gaspar de Toledo L; Dos Santos Ramos MA; Bento da Silva P; Rodero CF; de Sá Gomes V; Noronha da Silva A; Pavan FR; da Silva IC; Bombarda Oda F; Flumignan DL; Gonzaga Dos Santos A; Chorilli M; Gottardo de Almeida MT; Bauab TM
    Int J Nanomedicine; 2020; 15():10481-10497. PubMed ID: 33402821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical approaches in vulvovaginal candidiasis treatment with mucoadhesive thermoresponsive systems containing propolis.
    Bonfim AP; Sakita KM; Faria DR; Arita GS; Vendramini FAVR; Capoci IRG; Braga AG; Dos Santos RS; Bruschi ML; Becker TCA; de Oliveira Junior AG; Kioshima ÉS; de Souza Bonfim-Mendonça P; Svidzinski TIE
    PLoS One; 2020; 15(12):e0243197. PubMed ID: 33306677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.